270 likes | 431 Views
Slide 1. Presented By Maurice Perol at 2014 ASCO Annual Meeting. Conflict of Interest Disclosure. Presented By Maurice Perol at 2014 ASCO Annual Meeting. Limited Advancement in 2nd-Line Therapy. Presented By Maurice Perol at 2014 ASCO Annual Meeting. Ramucirumab and Angiogenesis.
E N D
Slide 1 Presented By Maurice Perol at 2014 ASCO Annual Meeting
Conflict of Interest Disclosure Presented By Maurice Perol at 2014 ASCO Annual Meeting
Limited Advancement in 2nd-Line Therapy Presented By Maurice Perol at 2014 ASCO Annual Meeting
Ramucirumab and Angiogenesis Presented By Maurice Perol at 2014 ASCO Annual Meeting
REVEL: Study Design Presented By Maurice Perol at 2014 ASCO Annual Meeting
Patient Eligibility Presented By Maurice Perol at 2014 ASCO Annual Meeting
Statistical Considerations for OS Presented By Maurice Perol at 2014 ASCO Annual Meeting
Patient Disposition Presented By Maurice Perol at 2014 ASCO Annual Meeting
Baseline Demographics<br />and Patient Characteristics Presented By Maurice Perol at 2014 ASCO Annual Meeting
Tumor Response by RECIST v1.1<br />ITT Population, Investigator Assessment Presented By Maurice Perol at 2014 ASCO Annual Meeting
Progression-Free Survival<br />ITT Population, Investigator Assessment Presented By Maurice Perol at 2014 ASCO Annual Meeting
Forest Plot of PFS by Subgroups<br />Unstratified Analysis Presented By Maurice Perol at 2014 ASCO Annual Meeting
Post-discontinuation Therapy Presented By Maurice Perol at 2014 ASCO Annual Meeting
Overall Survival<br />ITT Population Presented By Maurice Perol at 2014 ASCO Annual Meeting
Forest Plot of OS by Subgroups <br />Unstratified Analysis Presented By Maurice Perol at 2014 ASCO Annual Meeting
Safety Overview Presented By Maurice Perol at 2014 ASCO Annual Meeting
Selected Treatment-Emergent Adverse Events Occurring in ≥20% of Patients or ≥5% Higher in the RAM+DOC Arm Presented By Maurice Perol at 2014 ASCO Annual Meeting
Select AEs of Special Interest Presented By Maurice Perol at 2014 ASCO Annual Meeting
REVEL: Conclusions Presented By Maurice Perol at 2014 ASCO Annual Meeting
Acknowledgements Presented By Maurice Perol at 2014 ASCO Annual Meeting
REVEL Investigators Presented By Maurice Perol at 2014 ASCO Annual Meeting
Slide 22 Presented By Maurice Perol at 2014 ASCO Annual Meeting
OS by Histology Presented By Maurice Perol at 2014 ASCO Annual Meeting
PFS by Histology Presented By Maurice Perol at 2014 ASCO Annual Meeting
Slide 25 Presented By Maurice Perol at 2014 ASCO Annual Meeting
Slide 26 Presented By Maurice Perol at 2014 ASCO Annual Meeting